INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for HDFC Bank Ltd INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
The Company has issued duplicate share certificate as per details given below:- Name of the Shareholders : Hitesh A. Shah Folio No: 20793 No. Of shares: 100 Old Certificate No : 137464 Distinctive Nos; 82533001-82533100 New Certificate No; 209866 INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Closure of Trading Window
Pursuant to the provisions of the Code of Conduct for Prevention of Insider Trading, under SEBI (Prohibition of Insider Trading) Regulations, 2015, it is hereby informed that Trading Window for dealing in shares of the Company, will remain closed with effect from 1st July, 2023 till 48 hours after the declaration of un-audited financial results for the quarter ending 30th June, 2023. The date of the Board Meeting to consider the un-audited financial results for the quarter ending 30th June, 2023, shall be intimated separately. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI (LODR) Regulations, 2015, Stop Transfer Request processed by Registrar & Share Transfer Agent (RTA), Link Intime India Private limited is given below: Name of the Shareholder - MOHSNA KIDWAI Folio no. - 0003071 No. of shares - 500 Certificate Nos. - 30234 - 30238 Distinctive Nos. - 70443201- 70443700 Email received from the RTA is attached hereto. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
This is to inform you that the Company has received intimation from the shareholder on 16th June, 2023, regarding loss of share certificates. In accordance with Regulation 39(3) of the Regulations, the details of the said share certificates are as given below: Name of the Shareholder Folio no. No. of shares Certificate Nos. Distinctive Nos. Hitesh A. Shah 20793 100 137464 82533001-82533100 INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliance Intimation Pursuant To SEBI Circular No. SEBI/HO/MIRSD/MIRSD Pod-1/P/CIR/2023/37 Dated March 16, 2023
We hereby inform you that, pursuant to the SEBI Circular No. SEBI/HO/MIRSD/MIRSDPoD1/ P/CIR/2023/37 dated 16th March 2023 our RTA- Link Intime India Private Ltd. has dispatched the requisite communication letter(s) to the Shareholders of the Company holding shares in physical form requesting them to furnish PAN, KYC and nomination details in prescribed form/formats. The Confirmation of dispatch of said request letters from Link Intime India Private Ltd (RTA's of the Company) is attached herewith for your record. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 read with Schedule III (Part A) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit copies of the public notice of the financial results, published on 24th May, 2023, in the 'Financial Express', all India editions, in English language and in 'Jansatta', Delhi edition, in Hindi language. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Related Party Transactions For The Half Year Ended 31St March, 2023
Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit disclosure of Related Party Transactions for the half year ended 31st March, 2023. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Results For The Financial Year Ended 31St March, 2023 And Recommendation Of Dividend
This is to inform that the Board of Directors of the Company has, at its meeting held on Tuesday, 23rd May, 2023 (i.e. today), inter-alia : 1. Approved the Audited Financial Statements for the year ended 31st March, 2023 and Audited Financial Results for the quarter/year ended 31st March, 2023, as recommended by the Audit Committee; and 2. Recommended a dividend @ 30% i.e. Rs. 3.00 per share for the financial year 2022-23. The meeting of the Board of Directors commenced at 3.00 p.m. and concluded at 5:00 p.m. We shall inform you in due course of time, the date on which the Company will hold its Annual General Meeting for the year ended 31st March, 2023, and the date from which dividend, if approved by the shareholders, will be paid or warrants thereof dispatched to the shareholders. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 23Rd May, 2023
This is to inform that the Board of Directors of the Company has, at its meeting held on Tuesday, 23rd May, 2023 (i.e. today), inter-alia : 1. Approved the Audited Financial Statements for the year ended 31st March, 2023 and Audited Financial Results for the quarter/year ended 31st March, 2023, as recommended by the Audit Committee; and 2. Recommended a dividend @ 30% i.e. Rs. 3.00 per share for the financial year 2022-23. Pursuant to regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, The meeting of the Board of Directors commenced at 3.00 p.m. and concluded at 5:00 p.m. We shall inform you in due course of time, the date on which the Company will hold its Annual General Meeting for the year ended 31st March, 2023, and the date from which dividend, if approved by the shareholders, will be paid or warrants thereof dispatched to the shareholders.